2011
DOI: 10.1155/2011/425090
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Arrest Caused by Multiple Recurrent Pulmonary Embolism

Abstract: Pulmonary embolism is a common condition with a high mortality. We describe a previously healthy 68-year-old male who suffered three pulmonary embolisms during a short period of time, including two embolisms while on anticoagulant treatment. This paper illustrates three important points. (1) The importance of optimal anticoagulant treatment in the prevention of pulmonary embolism reoccurrence. (2) The benefit of immediate accessibility to echocardiography in the handling of haemodynamically unstable patients w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…There is currently no published experience with the new targetspecific oral anticoagulants and vitamin K antagonists, whereas limited data exist with prophylactic and therapeutic doses of low-molecular-weight heparin. 18,19,21,22,32,46 Alteplase is the only FDA-approved tissue plasminogen activator for PE and is the most commonly used and investigated agent. 10 The FDA-approved regimen is an infusion of 100 mg over 2 hours.…”
Section: Discussionmentioning
confidence: 99%
“…There is currently no published experience with the new targetspecific oral anticoagulants and vitamin K antagonists, whereas limited data exist with prophylactic and therapeutic doses of low-molecular-weight heparin. 18,19,21,22,32,46 Alteplase is the only FDA-approved tissue plasminogen activator for PE and is the most commonly used and investigated agent. 10 The FDA-approved regimen is an infusion of 100 mg over 2 hours.…”
Section: Discussionmentioning
confidence: 99%